Vaccines hope takes Bavarian Nordic's share price to more than 300 DKK

Monday saw lots of activity on Bavarian Nordic equity. According to a Danish bank analyst this owes to the potential of the firm's Covid-19 vaccine and a new order for the firm's smallpox vaccine.

Photo: Bavarian Nordic / PR

A Canadian order for smallpox vaccines worth DKK 195m (USD 31.3m) and continued speculation surrounding Bavarian Nordic's Covid-19 vaccine's glorious future has caused its share price to skyrocket in early Monday trading.

Following just over half an hour of trades, Bavarian increases further 9 percent to DKK 313.60 on top of the 36-percent appreciation from last week.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs